Phase 2 Study of a Chikungunya Vaccine in Previously Exposed Adults
Condition: Chikungunya Virus Infection Interventions: Biological: MV-CHIK; Other: Placebo Sponsors: Themis Bioscience GmbH; Walter Reed Army Institute of Research (WRAIR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials